SIMON OVANESSIAN: Open Payments
NPI 1376585091 · WESTBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,904 in 47 payments from 5 companies in 2025. Trend: 2023 $6,712 · 2024 $15,665 · 2025 $15,904
Consulting: $8,671Speaker / faculty: $3,220Travel & lodging: $2,527Food & beverage: $1,486
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 28 | $15,363 |
| Otsuka America Pharmaceutical, Inc. | 9 | $256 |
| Teva Pharmaceuticals USA, Inc. | 5 | $157 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $103 |
| Alkermes, Inc. | 1 | $25 |
Products named: COBENFY, ABILIFY MAINTENA, UZEDY, REJOYN, REXULTI, ARISTADA.
Industry payments across MA — which companies pay providers there.
